Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Acquisitions & Divestments (2017 - 2019)

Historic Change in Acquisitions & Divestments for Cogent Biosciences (COGT) over the last 3 years, with Q2 2019 value amounting to $8.0 million.

  • Cogent Biosciences' Change in Acquisitions & Divestments rose 1934.33% to $8.0 million in Q2 2019 from the same period last year, while for Dec 2019 it was $23.0 million, marking a year-over-year decrease of 3902.39%. This contributed to the annual value of $289.2 million for FY2025, which is 178.4% down from last year.
  • According to the latest figures from Q2 2019, Cogent Biosciences' Change in Acquisitions & Divestments is $8.0 million, which was up 1934.33% from $15.0 million recorded in Q1 2019.
  • Cogent Biosciences' Change in Acquisitions & Divestments' 5-year high stood at $15.0 million during Q4 2018, with a 5-year trough of $4.0 million in Q1 2017.
  • Its 3-year average for Change in Acquisitions & Divestments is $8.2 million, with a median of $6.4 million in 2017.
  • Within the past 5 years, the most significant YoY rise in Cogent Biosciences' Change in Acquisitions & Divestments was 20000.0% (2018), while the steepest drop was 1166.67% (2018).
  • Over the past 3 years, Cogent Biosciences' Change in Acquisitions & Divestments (Quarter) stood at $5.0 million in 2017, then surged by 200.0% to $15.0 million in 2018, then plummeted by 46.69% to $8.0 million in 2019.
  • Its last three reported values are $8.0 million in Q2 2019, $15.0 million for Q1 2019, and $15.0 million during Q4 2018.